IMMUVANCE
Dead / Abandoned — Abandoned — after publication (as of 16 Feb 2021)
What this means for you
This application is over — abandoned 16 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88956377
- Mark type
- Design + words
- Filed
- 09 Jun 2020
- Published for opposition
- 08 Dec 2020
- Abandoned
- 16 Feb 2021
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
- Class 042 — Scientific and technological services: scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
- Class 044 — Medical, beauty and agricultural services: providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Owner
- CytoDyn Inc., Vancouver, WA, US
- CytoDyn Inc., Vancouver, WA, US
Prosecution history
- 16 Feb 2021 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 16 Feb 2021 — ABANDONMENT - AFTER PUBLICATION
- 09 Feb 2021 — TEAS EXPRESS ABANDONMENT RECEIVED
- 21 Dec 2020 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 08 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Dec 2020 — PUBLISHED FOR OPPOSITION
- 18 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Nov 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Oct 2020 — ASSIGNED TO EXAMINER
- 07 Jul 2020 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 06 Jul 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Jun 2020 — NEW APPLICATION ENTERED